FDA Glass Syringe Guidance Aims To Solve Connectivity Problems
This article was originally published in The Gray Sheet
Executive Summary
Following a series of adverse events, an FDA draft guidance on glass syringes recommends supplemental tests to ensure device safety and effectiveness.
You may also be interested in...
BD Makes Pharma Debut With Generic Prefilled Syringe
BD gained FDA approval for the first in a line of prefilled generic injectable drugs that will be marketed by its new subsidiary, BD Rx.
Regulatory News In Brief
CDRH pursuing workplace fixes
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”